missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Siglec-2/CD22 Protein, Atto 647N Conjugate
Click to view available options
:
50 μg
Beschreibung
Measured by flow cytometry for its ability to bind anti-Human Siglec-2/CD22 Monoclonal Antibody conjugated fluorescent beads.
Spezifikation
Spezifikation
| Zugriffsnummer | CAA42006.1 |
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Zusammensetzung | Supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Gen-ID (Entrez) | 933 |
| Molekulargewicht | M.W. (Observed): 114-126 kDa, under reducing conditions, M.W. (Theoretical): 101.9 kDa (monomer) |
| Menge | 50 μg |
| Quelle | Mouse myeloma cell line, NS0-derived human Siglec-2/CD22 protein Human Siglec-2/CD22 (Asp20-Arg687) (N-terminus) Accession # CAA42006.1 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Lagerungsbedingungen | Protect from light. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening. 3 months, -20°C to -70°C under sterile conditions after opening. |
| Endotoxin-Konzentration | <1.0 EU per 1 μg of the protein by the LAL method. |
| Gen-Alias | B-cell receptor CD22, BL-CAM, B-lymphocyte cell adhesion molecule, CD22, CD22 antigenMGC130020, CD22 molecule, sialic acid binding Ig-like lectin 2, Sialic acid-binding Ig-like lectin 2, Siglec2, SIGLEC-2, SIGLEC2FLJ22814, T-cell surface antigen Leu-14 |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur